Preventing type 1 diabetes mellitus: The promise of gene therapy

American Journal of PharmacoGenomics

Volumn 2, Issue 2, 2002, Pages 129-134

  Efrat, Shimon ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; AUTOIMMUNITY; DISEASE PREDISPOSITION; DNA VECTOR; EARLY DIAGNOSIS; EFFECTOR CELL; GENE THERAPY; GENE TRANSFER; GENETIC SCREENING; IMMUNOLOGICAL TOLERANCE; IN VIVO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; REVIEW; SEROLOGY; ANIMAL; GENETICS; HUMAN; METHODOLOGY;

ANIMALIA;

ANIMALS; DIABETES MELLITUS, TYPE 1; GENE THERAPY; HUMANS;

EID: 0036326465     PISSN: 11752203     EISSN: None     Source Type: Journal    
DOI: 10.2165/00129785-200202020-00005     Document Type: Review

References (59)

1. Cell therapy approaches for treatment of diabetes
2. Genetic control of autoimmune diabetes in the NOD mouse
3. Diabetes in identical twins: A study of 200 pairs
4. Environmental factors in the pathogenesis of type I diabetes mellitus
5. Analysis of families at risk for IDDM reveals that HLA antigens influence progression to clinical disease
6. The first signs of beta-cell autoimmunity appear in infancy in genetically susceptible children from the general population: The Finnish Type 1 Diabetes Prediction and Prevention Study
7. Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives
8. Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes. A population-based study
9. Expression of GAD65 and islet cell antibody (ICA512) autoantibodies among cytoplasmic ICA+ relatives is associated with eligibility for the Diabetes Prevention Trial-Type 1
10. HLA-DQB1-defined genetic susceptibility, beta cell autoimmunity, and metabolic characteristics in familial and nonfamilial insulin-dependent diabetes mellitus
11. Tolerogenic strategies to halt or prevent type 1 diabetes
12. Diagnosis and treatment of pre-insulin dependent diabetes
13. Identification of a CD8 T cell that can independently mediate autoimmune diabetes development in the complete absence of CD4 T cell helper functions
14. Neonatal injection of CD3 antibody into nonobese diabetic mice reduces the incidence of insulitis and diabetes
15. Phase I evaluation of humanized OKT3: Toxicity and immunomodulatory effects of hOKT3gamma4
16. Activation of natural killer T cells by alphagalactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes
17. Roles of cytokines in IDDM pathogenesis and islet β-cell destruction
18. Reduced incidence and delayed onset of diabetes in perforin-deficient nonobese diabetic mice
19. The role of Fas in autoimmune diabetes
20. DNA fragmentation is an early event in cytokine-induced islet beta-cell destruction
21. Beta-cell apoptosis in T cell-mediated autoimmune diabetes
22. Cytokines induce deoxyribonucleic acid strand breaks and apoptosis in human pancreatic islet cells
23. Interleukin-1β-induced nitric oxide production in isolated rat pancreatic islets requires gene transcription and may lead to inhibition of the Krebs cycle enzyme aconitase
24. Interleukin-1β induces the expression of an isoform of nitric oxide synthase in insulin-producing cells, which is similar to that observed in activated macrophages
25. Apoptosis and the pathogenesis of IDDM. A question of life and death
26. p53 expression in nitric oxide-induced apoptosis
27. Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues
28. Transgenic copper/zinc superoxide dismutase modulates susceptibility to type I diabetes
29. Stable expression of manganese superoxide dismutase (MnSOD) in insulinoma cells prevents IL-1 beta-induced cytotoxicity and reduces nitric oxide production
30. Adenovirus-mediated catalase gene transfer reduces oxidant stress in human, porcine, and rat pancreatic islets
31. Pancreatic β cell-specific expression of thioredoxin, an antioxidative and antiapoptotic protein, prevents autoimmune and streptozotocin-induced diabetes
32. Dominant negative MyD88 proteins inhibit interleukin-1 beta/interferon-gamma-mediated induction of nuclear factor kappa B-dependent nitrite production and apoptosis in beta cells
33. SOCS-1 protein prevents Janus Kinase/STAT-dependent inhibition of beta cell insulin gene transcription and secretion in response to interferon-gamma
34. The molecular biology of apoptosis
35. Cell suicide for beginners
36. The Bcl-2 protein family: Arbiters of cell survival
37. Cytokine-induced apoptotic cell death in a mouse pancreatic β-cell line: Inhibition by bcl-2
38. Expression of the bcl-2 gene from a defective HSV-1 amplicon vector protects pancreatic β cells from apoptosis
39. Transfection of human pancreatic islets with an anti-apoptotic gene (bcl-2) protects beta-cells from cytokine-induced destruction
40. Lentivirus-mediated Bcl-2 expression in beta TC-tet cells improves resistance to hypoxia and cytokine-induced apoptosis while preserving in vitro and in vivo control of insulin secretion
41. A20 inhibits cytokine-induced apoptosis and nuclear factor kB-dependent gene activation in islets
42. Transgenic overexpression of human Bcl-2 in islet beta cells inhibits apoptosis but does not prevent autoimmune destruction
43. Overexpression of Bcl-x(L) in beta-cells prevents cell death but impairs mitochondrial signal for insulin secretion
44. Region E3 of adenovirus: A cassette of genes involved in host immunosurveillance and virus-cell interactions
45. Prolonged survival of murine pancreatic islet allografts mediated by adenovirus early region 3 immunoregulatory transgenes
46. Expression of adenoviral E3 transgenes in β cells prevents autoimmune diabetes
47. How virus induces a rapid or slow onset insulin-dependent diabetes mellitus in a transgenic model
48. Adenovirus early region 3 (E3) immunomodulatory genes decrease the incidence of autoimmune diabetes in nonobese diabetic (NOD) mice
49. Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic (NOD) mice
50. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse
51. Lentivirus-mediated transduction of islet grafts with interleukin 4 results in sustained gene expression and protection from insulitis
52. Abrogation of autoimmune diabetes in nonobese diabetic mice and protection against effector lymphocytes by transgenic TGF-β1
53. Transforming growth factor-β fails to inhibit allograft rejection or virus-induced autoimmune diabetes in transgenic mice
54. The paradoxical effects of interleukin 10 in the immunoregulation of autoimmune diabetes
55. Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI
56. Viral interleukin 10 (IL-10), the human herpes virus 4 cellular IL-10 homologue, induces local anergy to allogeneic and syngeneic tumors
57. Transfer of genes to humans: Early lessons and obstacles to success
58. Human gene therapy
59. Viral vector targeting